Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES (Details)

v3.25.1
SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
License and other revenues $ 3,500
Research and development costs    
Non-cash stock-based compensation 6,628 4,768
Total research and development costs 34,360 31,091
General and administrative costs    
Total general and administrative costs 29,851 19,004
Other segment items [1] (477) 7,593
Net loss (63,734) (54,188)
Research and Development Expense [Member]    
Research and development costs    
Salaries & related costs 15,345 11,373
Non-cash stock-based compensation 1,561 1,086
Other general and administrative costs [2] 17,454 18,632
General and Administrative Expense [Member]    
Research and development costs    
Salaries & related costs 10,729 6,942
Non-cash stock-based compensation 5,067 3,682
Other general and administrative costs [3] 9,237 7,156
General and administrative costs    
Pre-commercial preparation costs $ 4,818 $ 1,224
[1] Other segment items includes royalties, interest income, interest expense, change in fair value of warrant and derivative liabilities and other income.
[2] Other research and development expenses include, but are not limited to lab supplies, preclinical and development costs, clinical trial costs, manufacturing and manufacturing facility costs, costs associated with regulatory approvals, depreciation on lab supplies and manufacturing facilities, and consultant-related expenses.
[3] Other general and administrative expenses primarily consist of office facility costs, public reporting company related costs, professional fees (e.g., legal expenses) and other general operating expenses not otherwise included in research and development expenses.